![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 45, 42477-42484, November 9, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biochemistry, Emory University School of
Medicine, Atlanta, Georgia 30322-3050 and the
Received for publication, July 16, 2001, and in revised form, August 29, 2001
Structures were determined by x-ray
crystallography for two members of the ADP-ribosylation factor
(ARF) family of regulatory GTPases, yeast ARF1 and ARL1, and
were compared with previously determined structures of human ARF1 and
ARF6. These analyses revealed an overall conserved fold but differences
in primary sequence and length, particularly in an N-terminal loop,
lead to differences in nucleotide and divalent metal binding. Packing
of hydrophobic residues is central to the interplay between the
N-terminal ADP-ribosylation factor
(ARF)1 and ARF-like (ARL)
proteins comprise the ARF family within the Ras superfamily of
regulatory GTPases. Members of this superfamily function as molecular
nodes in signaling that can directly activate one or more enzymatic activities or coordinate the recruitment and assembly of more elaborate
multisubunit complexes. The conformational changes that accompany the
binding of GDP and GTP can lead directly to changes in the affinity of
the GTPase for proteins, lipids, and membranes. For Ras superfamily
members these conformational changes are centered in two functional
regions, referred to as switch I (SW1) and switch II (SW2) (1). Members
of the ARF family have an additional nucleotide-sensitive region, an
extension at the N terminus and a covalently attached myristate that
together work as a "myristoyl switch" to coordinate activation (GTP
binding) with translocation onto a membrane (2). In addition to its
role in membrane binding, there is also evidence that the N terminus
may influence effector binding or activities (3, 4). Residues in SW1
and SW2 make direct contacts with effectors and GTPase-activating
proteins (GAPs) in a variety of GTPases, including ARFs (5, 6). It has
been proposed that the two switches in ARF may act to coordinate the
binding and activities of two different proteins simultaneously, a GAP
and an effector, to effectively coordinate recruitment of vesicle cargo
and GTP hydrolysis (6). However, the N-terminal region (residues 1-17)
of ARF have been shown to be sufficient to confer ARF activity and
increased GTPase activity to an ARL protein despite the distance
between the N terminus and switch or nucleotide binding region (3).
These data highlight the complexity of interactions as well as the
novel mechanisms of regulation of ARFs as compared with other members
of the Ras superfamily.
The distinction between ARFs and ARLs is based on both sequence
relatedness and function (7). There are six mammalian ARFs and more
ARLs, while the yeast Saccharomyces cerevisiae has only two
ARFs and two ARLs. ARFs all share at least 60% identity in primary
sequence and are active as (i) co-factor in the cholera toxin-catalyzed
ADP-ribosylation of G Structures have been determined by x-ray crystallography of the two
most divergent human ARFs, ARF1 and ARF6 (10, 11), and also for the
ARF-like protein murine ARL3 (18). These structures have
revealed the fundamental conservation of structure between ARFs and
other members of the Ras superfamily in the six Protein Expression and Purification--
ScARF2 and ScARL1 were
expressed in BL21(DE3) bacteria using the pET3C expression plasmid as
described previously for other ARF proteins (12). Cells were grown to
an A600 of 1.0 before protein expression
was induced with isopropylthio- Crystallization, Data Collection, Structure Determination, and
Refinement--
Crystals of ScARF2 were grown by the hanging drop
method combining equal volumes (2 µl) of the protein stock and mother
liquor (20% polyethylene glycol 8000, 0.1 M
cacodylate, pH 6.5) at room temperature. ScARF2 crystals grew as thin
plates (0.3 × 0.06 × 0.02 mm3) from a central
hub and had to be separated before vitrification in 30% polyethylene
glycol 8000, 0.1 M cacodylate, pH 6.5 and 15% glycerol
using liquid propane. ScARL1 crystals were also obtained by the hanging
drop (20% polyethylene glycol 8000, 15% glycerol, 0.1 M
Tris, pH 8.5). Statistics for the structure determination are shown in
Table I. For ScARF2, data collection to better than 1.6 Å was
performed at the Brookhaven National Laboratory X12b beam line
( Mass Spectrometry--
Nucleotide bound to ScARF2 was released
by the addition of ice-cold HClO4 to a final concentration
of 0.5 M, incubation at 0 °C for 10 min, removal of
precipitated protein by centrifugation, and neutralization of the
supernatant by addition of ScARF1 and ScARF2 are over 97% identical and share about 74%
identity with mammalian orthologs, e.g. HsARF1 or HsARF6
(see Fig. 1A). ScARF1 and
ScARF2 were each expressed in bacteria, purified to homogeneity, and
crystallized as described under "Materials and Methods." Crystals
of ScARF2 diffracted to higher resolution (1.6 Å) and the resultant
structure provided details not seen in previous ARF structures.
Comparisons between yeast (ScARF2) and human (HsARF1 (10) and HsARF6
(11)) structures provide insights into conserved features throughout
this evolutionary distance. We have also crystallized and solved a
structure for yeast ARL1 (ScARL1) at a lower resolution (3.2 Å). Data
and model statistics for each new structure are shown in Table
I. Because of the functional differences
between ARFs and ARLs (9) and greater divergence in sequence (40-60%
identity) the variations between the structures provide details of
structural divergence of likely functional importance.
The secondary structures of GDP-bound ScARF2, ScARL1, and HsARF1 are
essentially conserved (see Fig. 1B); the topology includes seven Bacterially Expressed ScARF2 Contains Either Bound GDP or
GDP-3'-phosphate--
Higher affinity for GDP over GTP and lipid
dependence on the binding of activating guanine nucleotides likely
explain the presence of GDP in the nucleotide binding site of ARFs as
purified from mammalian tissues or bacteria (17). GDP was well fit in the binding site of previous ARF structures and in both yeast proteins
described here. But there remained clear, but unexplained, density at
the 3' position of the ribose bound to ScARF2. Different orientations
of the ribose were considered, but only a covalent modification at the
3' position could be fit well (see Fig.
2A). The presence of a
modified GDP in the protein preparation used to produce the ScARF2
crystals was investigated using mass spectroscopy. The presence of GDP,
with the predicted mass of 442 atomic mass units, was evident in
the preparation as was the presence of a second species with a mass of
522 atomic mass units. The mass of the larger species was consistent
with a modification to GDP that adds 80 atomic mass units and can be
explained by an additional phosphate (HPO3). We estimate
from the mass spectroscopy results and the electron density in the
crystal structure that our preparation of ScARF2 has ~70% GDP and
30% GDP-3'-phosphate bound. This is the first modified nucleotide
found on a regulatory GTPase as purified, although no biological
significance can yet be ascribed to this observation.
The high resolution of the ScARF2 structure also allowed the definition
of alternate conformations of side chains that were not evident
in previous structures as well as the binding of a number of small
molecules. For example, the invariant lysine
(A2:K30),2 which
contacts the
In addition to more than 200 water molecules, the surface of the
protein was found to bind two glycerol, one 1,3-propanediol, nine
1,2-ethanediol, and three ethanol molecules per protein monomer, all
introduced by the use of glycerol as cryoprotectant. The most provocative of the binding sites for these molecules is the channel extending from the nucleotide and magnesium binding site (Fig. 2B). The fact that this channel is lined by residues
involved in magnesium binding (Glu54 and Asp67)
and residues of the lower ISR (Asn52) as well as SW1
(Thr48 and Phe51) and SW2 (not shown) leads us
to speculate a potential for this being a site of interaction with
lipid, or other modulators, that could promote nucleotide exchange or
conformational changes in one or both switches.
Homodimer Formation of ScARL1--
Similar to murine Arl3-GDP (18)
a covalent homodimer was observed for ScARL1; however, here the
disulfide bond is within the asymmetric unit and is linking the two
Cys81 residues present in SW2 (Fig.
3). Dimerization was not the result solely of crystallization as it was detectible by either nondenaturing polyacrylamide gel electrophoresis or high-resolution gel filtration chromatography (results not shown) prior to crystallization. This is
the only known example of a covalent homodimer being formed by a member
of the Ras superfamily. Recently ARF1 and Ras were proposed to form
homodimers on 3membranes (19,
20). Indeed membrane localization promotes dimer formation of Ras,
which is essential, although not sufficient, for activation of its
target molecule, Raf-1 (20). Dimerization also appears to be involved
in the regulation of the activity of Rho family GTPases (21). To test
the functional importance of dimerization we constructed the C81S
mutant of ScARL1 and integrated it at the ARL1 locus by
homologous recombination. This point mutant was fully functional as
defined only by rescue of the cold sensitivity seen in
arl1
The model for ScARL1 reported here includes a disordered gap at
residues 71-74 because of the lack of density to model the structure
appropriately. This region is the start of SW2 and typically has the
highest crystallographic thermal values in GTPase structures. In
contrast, the structure of the entire SW2 region of ScARF2 is well
defined and completely determined, possibly due to the crystal contacts
present in this area. Similarly, the entire SW2 region of the ARL3
structure could be modeled (18).
Differences in Electrostatics between HsARF1, ScARF1, HsARF6, and
ScARL1--
Comparison of the electrostatic surface of HsARF1, ScARF1,
HsARF6, and ScARL1 revealed striking differences that are consistent with their membrane interactions. The electrostatic profiles of the
four proteins fall into three categories: a patched surface, a
primarily acidic surface potential, or a primarily basic surface potential (Fig. 4). HsARF1/ScARF2
comprise the group distinguished by the patched appearance of both
anionic (negative potential in red) and cationic (positive
potential in blue) areas as seen in Fig. 4, A and
B. These patches of mixed charge, including SW1 and SW2,
when positioning the N terminus toward the membrane, would provide a
distinctive surface for protein interactions oriented toward the
cytosol. Most prominent for HsARF1/ScARF2 is a horseshoe-shaped acidic
cushion surrounding the N-terminal helix, which itself is predominantly
basic (Fig. 4, A and B). Such a charged surface may assist in the orientation of the ARF1 to promote the interaction of
the N terminus and the covalently bound myristate with membrane lipids.
This may also help explain the ability of acidic lipids to promote
nucleotide exchange through interaction with the N-terminal region
(22).
The surface of ScARL1 is distinguished by an overall negative
electrostatic potential (see Fig. 4C). Like HsARF1, both
human and yeast ARL1 are N-myristoylated, yet we have been
unable to demonstrate4 any
GTP-dependent binding of HsARL1 to membranes or lipid
vesicles that is a hallmark of ARFs (23). These observations lead us to
predict that the binding of human and yeast ARL1 to membrane is more
dependent on protein-protein interactions at the membrane than is the
binding of ARFs.
In contrast to the two profiles described above, the electrostatic
potential of HsARF6 gives the protein a primarily cationic appearance
(see Fig. 4D). Interestingly the location on the surface of
HsARF6 that surrounds and includes the N-terminal helix is strongly
basic. An increased tendency to interact with acidic head groups of
lipids would be predicted from such an electrostatic profile, and this
may contribute to the finding that ARF6 more tightly associates with
membranes even when GDP is bound.
Despite the variation of the electrostatic potential for all four
proteins as described above, there is one consistent observation among
them. The highly conserved loop L-SW1/ Structural Comparisons of the Four GTPases--
To identify
structural differences between the four ARF family members, we aligned
the structures of ScARF2, ScARL2, and HsARF6 against HsARF1. For an
optimal alignment, one that would highlight the differences and
maintain invariant features, we first superimposed the backbone
C
The largest differences were found at the N terminus (A1:2-19), the
switch regions (SW1 = A1:36-52 and SW2 = A1:69-85), and the
ISR (loop L-2/3, A1:57-62). Further prominent r.m.s. differences were
found in regions A1:129-133 and A1:149-151. Amino acids 129-133 are
adjacent to the highly conserved 126NKQD129
sequence, which is directly involved in the binding of the guanine nucleotide base. Residues 149-151 are close to the GAP binding site as
described by Goldberg (6). Structural changes with a smaller r.m.s.d.
were found in regions A1:100-120, at A1:27, and centered around A1:162
(see Fig. 5). Residues 100-120 are involved in binding to ARF-GAP (6).
Residue 27 is part of the putative phosphate binding sequence
GX4GK. Residue 162 follows a group of
residues involved in binding the guanine base as discussed in more
detail below. That these differences in structure are scattered
throughout the molecules and are mostly located in previously identified regions essential to function are consistent with these being functionally important regions and useful in defining specificity between the proteins.
The Packing of a Hydrophobic Cluster, Made Up of Residues from the
N Terminal Helix, SW1, and the Interswitch Region, Allows the N
Terminus to Influence the Structure of SW1--
Membrane binding,
nucleotide affinity, phospholipid dependence of GTP binding, and
nucleotide hydrolysis by ARFs are all sensitive to the presence and
sequence composition of the N-terminal 17 amino acids; they are the
A more detailed comparison of these areas is shown in Fig.
6. A key to the organization of these
regions is the presence of hydrophobic residues, best viewed in HsARF1
(Fig. 6A), which include Phe5, Phe9,
Leu37, Leu39, Val56,
Tyr58, Ile61, and Phe63, forming a
hydrophobic cluster. Note, in particular, the extent to which
Leu39 is inserted into the cluster and makes direct contact
with the N-terminal helix. In HsARF6 (Fig. 6B) the
equivalent is Leu35, but it is much less well fit into this
cluster due to the shortening of loop L-Nt, a four-residue deletion
relative to HsARF1 (Fig. 1A), and the presence of a leucine
residue (Leu5) instead of a phenylalanine
(Phe5), as in HsARF1(Fig. 6A). These changes
lead to a reorientation of the ISR and specifically Tyr54.
The result is a large change in the structure of the N-terminal portion
of SW1 of HsARF6. In contrast, loop L-Nt is much longer in ScARL1,
allowing yet other structural differences in the ISR. When coupled with
the change to L1:I40 (corresponding to A1:L39)
this allows the first part of SW1 to make closer contacts and additional hydrogen bonds with the ISR (Fig. 6C). Although
ScARF2 (Fig. 6D) has a shorter loop L-Nt than HsARF1, the
conserved Leu39 and hydrophobic cluster prevent the change
in SW1 seen in HsARF6 and ScARL1. In ARL3, differences in the structure
of the N terminus and ISR result from differences in key residues,
e.g. a lysine instead of glutamate at position 54 and the
two phenylalanines in ARF1, Phe5 and Phe9, are
serine and lysine, respectively, in ARL3 (18). Thus, we conclude that
the different packing of hydrophobic residues modified by contributions
from the N-terminal helix and the ISR, in addition to the variation in
length of loop L-Nt, lead to differences in the initial portion of SW1.
The presence of this hydrophobic cluster, the degree of residue
insertion, and the ability of backbone hydrogen bond formation
are most likely the principal causes for the change in structure at the
start of the SW1 region.
Differences in the Binding Sites for Magnesium and
GDP--
Glutamate 50 of HsARF6 influences nucleotide exchange,
probably through effects on the binding of Mg2+ (11). This
glutamate (A6:E50, A1:E54) cannot approach the
metal to make the contacts seen in ARF1 (see Ref. 10 and Fig.
7, A and B), and
thus a weakening of the affinity for Mg2+ was predicted
(11). We find similar structural variations in ScARL1 and ScARF2 that
are also predicted to have an impact on the affinity for magnesium
(Mg2+) and consequently nucleotides (Fig. 7, C
and D). This may explain the observations that indicate each
of these proteins exchange nucleotides more rapidly than HsARF1. It may
also explain the absence of bound Mg2+ for some of the
published structures (11, 18).
The predicted differences in affinity for magnesium result from an
increase in distance, i.e. decrease in interaction, between a conserved glutamate (A1:E54, L1:E55),
involved in binding of the Mg2+, and a conserved tyrosine
hydroxyl (A1:Y35, L1:Y36). This results from
structural changes and sequence variations in the SW1 area,
specifically at residues A1:40-42 (L1:41-43). In ScARL1 (Fig.
7C), the modified positioning of L1:I40,
including the flip of its
Nucleotides bind to ARFs through interactions above and below the plane
of the base. On one face are side chains from the second conserved
G-domain, NKQD (A1:N126-D129) in the ARF
family, and on the other face is a less conserved residue
(A1:T161). Given the importance of these interactions and
their conservation among GTPases it was surprising to note that after
the N-terminal region, SW1, and SW2, the region with the highest r.m.s.
deviation between structures (>1 Å) is found in loop L-5/D,
A1:130LPNA133, immediately following
A1:D129. A1:K127 (not shown) interacts
hydrophobically along the face of the base while Asp129
forms a hydrogen bond at the edge of the base. While these interactions were conserved in all four structures the distances of the bonds formed
and orientations of side chains differed in ways that may predict
differences in nucleotide affinities or handling. Not only does the
r.m.s. analysis (Fig. 5) show substantial differences between the
backbones in this G-domain, the side chains are oriented differently as
well. A change in the residue corresponding to A1:N132 is
always coordinated with a concomitant change at residue
A1:N95 (see Fig. 1A). These residues are on
loops that interact with each other, and it is the type of interaction,
which can vary with sequence changes, that causes the larger r.m.s.
deviation at the location of loop L-5/D.
On the other side of the base is the less conserved sequence
(A1:158TCAT161) that provides
A1:T161 for base interactions, but this interaction appears
much less strong. The density for A2:T161 indicates this
residue is rotating through about 90°. It is also hydrogen bonding
with a water molecule. The sequence at this position varies within the
ARF family and can be a valine, isoleucine, leucine, or alanine in
different ARLs. Structural variation at the guanine base sandwich due
to A1:T161 and Asp129 (in turn due to
structural perturbations in the subsequent loop residues 130-133) most
likely influences the ability of the protein to bind the base of the
nucleotide and therefore influences the affinity of the nucleotide,
similar to differences in the binding of magnesium. A rank order in
predicted affinity for GDP is difficult as it results from at least
three factors that do not necessarily exert their effect in a
coordinated fashion: the residue at position A1:T161, the
proximity and mobility of residues
A1:D129-L130, and the orientation of
A1:N132 resulting from its interaction with
A1:N95.
Another ARL structure, that of ARL2(GTP) bound to
the *
This work was supported by National Institutes of Health
Grant AI43996 (to J. C. A., X. Z., J. H., and R. A. K.) and the
Georgia Research Alliance.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom all correspondence should be addressed: Dept. of
Biochemistry, Emory University School of Medicine, 1510 Clifton Rd., Atlanta, GA 30322-3050. Tel.: 404-727-3561; Fax: 404-727-3746; E-mail:
rkahn@emory.edu.
Published, JBC Papers in Press, September 4, 2001, DOI 10.1074/jbc.M106660200
2
In discussing comparisons between the four ARF
family members we use the numbering for HsARF1 as the benchmark
for this family. Residue numbering in HsARF1 (PDB code 1HUR) is
indicated by the abbreviation A1:"residue," in ScARF2 as
A2:residue, in ScARL1 as L1:residue, and in HsARF6 (PDB code 1E0S) as
A6:residue. Single letter abbreviations are used for amino acids in
this numbering scheme.
3
A. G. Rosenwald, M. Rhodes, H. Van
Valkenburgh, G. Chapman, J. Shu, V. Palanivel, C. J. Testa, A. B. Boman, C. J. Zhang, and R. A. Kahn, submitted.
4
H. Van Valkenburgh, J. D. Sharer, and R. A. Kahn, unpublished observations.
The abbreviations used are:
ARF, ADP-ribosylation factor;
ARL, ARF-like;
GAP, GTPase activating protein;
ISR, interswitch region;
r.m.s., root mean square;
r.m.s.d., root mean
square deviation;
SW1, switch I;
and SW2, switch II;
Structures of Yeast ARF2 and ARL1
DISTINCT ROLES FOR THE N TERMINUS IN THE STRUCTURE AND FUNCTION
OF ARF FAMILY GTPases*
,
,
Department
of Biochemistry and Chemistry, Rosenstiel Basic Medical Research
Center, Brandeis University, Waltham, Massachusetts 02454
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
-helix, switch I, and the interswitch region, which along
with differences in surface electrostatics provide explanations for the
different biophysical and biochemical properties of ARF and ARF-like proteins.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
s, (ii) direct activators or
phospholipase D, and (iii) suppressors of lethality resulting from the
deletion of the two yeast ARF genes. The biological roles of
ARFs are central to many steps in vesicular traffic, particularly those
involving the Golgi (8). In contrast, ARLs share 40-60% sequence
identity with each other or with any ARF and lack each of the ARF
activities described above (9). Much less is known about biological
roles, protein effectors, or the importance of membrane-lipid
interactions for the ARLs. That ARFs are essential and highly conserved
throughout eukaryotic evolution is highlighted by the findings that at
least one ARF has been found in every eukaryote tested (although not
yet in any prokaryote) and that each one tested has demonstrated the
ability to complement the arf1
rf2
double
mutant in yeast.
-strands at the core
of the protein and surrounding helices. We report here structures of
GDP-bound, S. cerevisiae ARF2 (ScARF2) and ARL1 (ScARL1), as
determined by x-ray crystallography to 1.6 and 3.2 Å resolution,
respectively. The structures of the two proteins show changes in and
surrounding the N terminus. These differences give indications of how
the diverse biochemical characteristics may be determined or mediated
by the sequence and structure of the N terminus. In addition,
comparison of surface electrostatics of the four ARF family members
revealed surprisingly large differences that are discussed with respect
to properties of each protein.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
-D-galactoside (0.5 mM). Cells were harvested by centrifugation after ~12 h
of growth at 37 °C. Cells were resuspended in 25 mM
Tris, 50 mM NaCl, 1 mM MgCl2, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl
fluoride, 50 µM GDP, pH 7.5 before lysis using a French
press. Bacterial cell lysate was passed over a low substituted Q-Macro
column (Bio-Rad; 100-ml bed volume) in the same buffer, and the
flow-through was applied to a high substituted Q-Macro column (Bio-Rad;
50-ml bed volume). A linear gradient (50-350 mM NaCl, 500 ml) in lysis buffer was used to fractionate proteins. Pooled fractions
were concentrated to 5 ml and loaded on a Sephacryl S-100 HR (Amersham
Pharmacia Biotech; 60 cm, 300-ml bed volume) gel filtration column.
Protein purity was determined by denaturing (SDS) polyacrylamide gel
electrophoresis, and the pooled fractions were concentrated to a final
concentration of 1 mM protein for storage at
80 °C.
= 1.008 Å). One-degree oscillation frames were integrated with DENZO, then merged, and scaled with SCALEPACK from HKL
(13). Initial phases for the structure factors were determined by
molecular replacement with AMoRe (14) using HsARF1-GDP (10) as the
search model. For both proteins the final model was established by
successive rounds of structure building using O (15) and refinement
with CNS (16) (Table I).


H)
ions of m/z 442.3 or
522.4. Data was acquired for a total of 1.7 min, thus each spectrum was
the signal-averaged sum of ~100 scans. Precursor ion spectra were
acquired to detect either m/z 79.0 or 150.0. Data
was acquired for a total of either 2.5 or 5.0 min, respectively, thus
each spectrum was the signal-averaged sum of 300 scans. Nitrogen was
used to collisionally activate precursor ion decomposition.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

View larger version (46K):
[in a new window]
Fig. 1.
Secondary structure, sequence, and structural
alignment of Arf proteins. A, alignments of the primary
sequences of HsARF1 (Protein Sequence Database (PIR) entry A33283),
ScARF2 (PIR A36367), ScARL1 (PIR S46035), and HsARF6 (PIR
B23741) are based on the three-dimensional model of HsARF1. Numbering
and the secondary structure scheme are relative to HsARF1, but to avoid
ambiguity, every 10th residue is in green. The secondary
structural fold is indicated by arrows for
-strands and
cylinders for
-helices. The coloring scheme is followed
throughout Figs. 2 and 4-7. GDP binding sequences are shaded in
cyan, regions of an average r.m.s.d. >0.5 Å are shaded in
yellow, residues involved in the interplay between the N
terminus, switch I, and the ISR are shaded in magenta.
B, comparison by superposition of the C
trace of ScARF2,
ScARL1, and HsARF1. HsARF1 is indicated in black, ScARF2 in
red, and ScARL1 in orange. Note that the C
trace of even distant family members, such as ScARL1, is well
maintained. The ISRs are indicated, and the GDP binding site is toward
the front of the plane between SW1 and SW2. The bound GDP is
represented as a ball-and-stick model, and the bound
Mg2+ is represented as a colored sphere. No
Mg2+ was detected bound to ScARL1. Substantial variations
exist in the placement of
NT and the length of the loop L-Nt
connecting the N-terminal helix and the first strand (toward the
back of the plane) as well as the start and end of SW1
(top and bottom of arrow) and throughout SW2.
Ct, C-terminal
-helix.
Statistics for x-ray structures reported here
-strands, six
-helices, and 12 connecting loops. Of these, the protein core is an invariant six-stranded
-sheet surrounded by
six
-helices. The seventh strand forms an edge to the core and
corresponds to the functionally important SW1 region seen in regulatory
GTPases (1). The N-terminal region of each protein is an
-helix
(
Nt) wedged between the C-terminal helix
-E and loop L-2/3, which
connects strands
2 and
3, also referred to as the interswitch
region (ISR). The presence of
Nt is in contrast to the rather
undefined secondary fold seen for the N-terminal sequence in the ARL3
model (18). SW2 corresponds to L-3/B and
B, where L-3/B is on the
opposite side of the N-terminal region and
B is opposite the bound
GDP. The nucleotide binding site is on the surface of the protein
between
Nt and SW2 (Fig. 1B).

View larger version (34K):
[in a new window]
Fig. 2.
Modified GDP and polyols bound to ScARF2 and
additional interactions between GTPases and other molecules.
A, omit map of GDP-3'-phosphate. Mass spectrometry indicated
the presence of a 3'-phosphate, which could be readily modeled; density
of an omit map of the 3'-phosphate at 2.5
is in royal
blue, of the GDP (excluding the 3'-PO4) in
cyan at 3.0
, and of the Mg2+ in
green at 5.0
. B, binding of polyols in a
"channel" formed by the lower ISR, strands
2 and
3, in
ScARF2. Due to the high resolution of the data (1.6 Å), a few and
distinct variety of small molecules are found bound to the surface of
ScARF2. In addition to water molecules, polyols such as glycerol and
1,3-propanediol, introduced by the use of glycerol as a cryoprotectant,
are seen bound to the surface. A feature of the surface of ScARF2 is a
channel or "cleft" between strands
2 and
3 in an area
centered around SW1, the Mg2+ binding site, and SW2.
Illustrated is a GRASP (25) model showing the electrostatic surface of
ScARF2, indicating the presence and position of the channel as well as
the glycerol, 1,3-propanediol, and GDP-3'-phosphate
(GDP3'P) molecules (green), surrounded
by the molecule VanderWaals radius model (yellow).
The inset shows part of the protein residues affected and
the location of the polyols in greater detail. The electron density, in
royal blue, is an omit map of the polyols rendered at
2.75 s. The insert was generated with MOLSCRIPT (26).
- and
-phosphates, has alternate conformations for
the
- and
-carbons. Only one of these conformations is observed for all the ARF family members structures published to date, except the
HsARF1·GDP·GAP structure (6), which has the other conformation. Our
results show both conformations simultaneously present for Lys30 in ScARF2.
cells. Thus, there is no evidence to
support a required role for dimerization, covalent or otherwise, of
ScARL1. However, both ARFs and ARLs have conserved cysteines;
e.g. all known ARL1 orthologs have a cysteine at the
position homologous to L1:81, while ARL2 orthologs lack that cysteine
but have one at position 103 (A1:102).

View larger version (26K):
[in a new window]
Fig. 3.
Dimerization of ScARL1. A covalent dimer
is seen as a result of a cystine bridge at Cys81 in SW2 of
ScARL1. The C
traces of part of the SW2 region of the two separate
molecules (indicated as ScARL1 A and ScARL1 B)
are shown in green and magenta, respectively. The
electron density in royal blue is of an omit map of
Cys81 from each molecule rendered at 3.0
. The distance
between the sulfurs of the two cysteines, indicated in
yellow, is modeled at 2.1 Å.

View larger version (50K):
[in a new window]
Fig. 4.
Electrostatic potential of ARF family
proteins at ±kT/e as determined by GRASP (25). An
electrostatic representation of HsARF1 (a), ScARF2
(b), ScARL1(c), and HsARF6 (d) with no
bound nucleotide or Mg2+ was modeled by contouring the
electrostatic isopotential at an energy of ±kT/e,
where k is Boltzmann's constant, T is temperature, and e is the
electron charge. Each of the four proteins are displayed in the same
orientation, depicted using a ribbon diagram for HsARF1 in
e. For ScARL1 some long chain residues on the surface such
as glutamate and arginine or lysine were included even when no exact
position could be established through the electron density. Areas of
negative potential are shown in red (acidic residues), and
areas of positive potential are shown in blue (basic
residues). Hydrophobic areas are shown in gray. The
differing size or volume of the potential, i.e. the distance
from the edge of the electrostatic potential to the surface of the
molecule, is due to differing charge densities. For example, comparison
of ScARF2 to ScARL1 clearly indicates substantial differences in both
charge composition and density. Note the consistent exposure of loop
L-SW1/
2, the polar nature, and the directionality or sidedness of
the electrostatic potential for the different molecules.
2 is electrostatically isolated, both due to its exposure at the surface and its predominantly hydrophobic nature (especially noted for ScARL1 in Fig.
4C).
-atoms of the highly invariant fourth, fifth, and sixth
-strands. The r.m.s.d. for all C
-atoms was then calculated and plotted against the sequence position as shown in Fig.
5.

View larger version (35K):
[in a new window]
Fig. 5.
r.m.s. deviation of the backbone
C
of ScARF2, ScARL1, and HsARF6 relative to
HsARF1. C
-atoms of
-strands 4, 5, and 6 for ScARF2
(red), ScARL1(green), and HsARF6
(blue) were fitted against the C
-atoms in HsARF1 (Ref.
10, A molecule in PDB code 1HUR) of the equivalent
-strands
(gray box,
4 residues
A1:G87-D93,
5 residues
A1:A119-N126, and
6 residues
A1:W153-T158). The average r.m.s.d. was
calculated for this fitted region (ScARF2, 0.2 Å; ScARL1, 0.4 Å;
HsARF6, 0.3 Å), and after this optimal fit, the C
r.m.s.d. for each
residue in all three proteins was plotted in Å against residue number.
Areas with gaps or insertions were excluded (black
box, excluded residues 70-74 for all proteins; red
box, nonmodeled residues 2-5 for ScARF2; blue box, gap
for HsARF6; insertion of Ser15 for ScARL1, not
indicated). To assist with correlations to the three-dimensional model,
a cartoon of the secondary structure is shown below
the graph. Fitting was performed using the McLachlan algorithm (27) as
implemented in the program ProFit (28).
Nt and loop (L-Nt) comprising the "N-terminal region" (3, 22).
The structure and position of this region has only been determined for
ARF(s) bound to GDP and is presumed to change dramatically upon binding
GTP (5). How the presence or structure of the N-terminal region can so
dramatically influence the nucleotide binding site has been the subject
of much conjecture. A comparison of the four structures illustrates how
the sequence of the N-terminal helix and the length of the following
loop L-Nt can affect the structure of SW1 and the interswitch region
and in so doing the nature of the nucleotide bound. In essence, the presence of the N-terminal region constrains the ISR (loop L-2/3), a
primary determinant of the bound nucleotide. The largest differences detected from the comparison of the four structures were in these three
elements: the N-terminal region, the ISR, and SW1. Differences in the
N-terminal region (most obviously the lack of
Nt) and the ISR were
also reported for the recent structure of ARL3 (18).

View larger version (48K):
[in a new window]
Fig. 6.
Variations in the
NT, ISR, and SW1 region. Residues in the
N-terminal helix (magenta), loop L-Nt (green),
and residues of L-2/3, the interswitch region (indigo)
modify the secondary structure at the start of the switch I sequence
(red). The yellow dashed line indicates backbone
hydrogen bonds between SW1 and
2. The nucleotide and binding helix
A are in cyan. HsARF1 (a) and HsARF6
(b), without electron density, are shown for comparison.
Omit maps of residues 38-45 for ScARL (c) and 37-44 for
ScARF2 (d) were calculated and are shown in royal
blue at 3.0 and 3.5
, respectively. Note the variation in
positioning of A1:L39 versus A2:L39
versus L1:I40 versus
A6:L35 as well as the effect on the C
trace and the
additional hydrogen bond between SW1 and
2 in ScARL1
(L1:E42-S58). In ScARL1 the length of loop
L-Nt has an effect on the ISR by influencing the extent of the
insertion of L1:I40 as well as allowing for the formation
of new backbone hydrogen bonds. The anchoring of L1:I40,
combined with the flip of its
-angle (L1:I40:
= 165°, 0 =
136°; A1:L39:
=
7°, 0 =
94°), leads to a maximal repositioning by about 3 Å for the
subsequent three residues (41) in this part (SW1) of ScARL1
relative to the equivalent HsARF1 residues (see a and
c). The
-angle flip between L1:I40 and
L1:G41 also enables a new antiparallel hydrogen bond in the
-strands between L1:E42(CO)-L1:S58(NH) (2.9 Å) and L1:V44(NH)-L1:T56(CO) (2.9 Å)
(see c). A2:L39 is also buried in a hydrophobic
cluster, but residues in the ISR and a substantial shortening of the
N-terminal loop, concomitant with the repositioning of the N terminus
itself, cause a displacement of the ISR toward the N terminus. This
movement apparently abrogates the formation of a new hydrogen bond in
the antiparallel
-strands between
A2:E41(CO)-A2:E57(NH) (4.9 Å), thereby
preventing the flip of the
-angle between A2:L39 and
A2:G40. In this manner the residues around residue
A2:L39 (d) maintain the same conformation seen
in HsARF1. The presence in HsARF6 of a leucine at position 5, where the
corresponding residue is a phenylalanine in the other three proteins,
causes the N-terminal helix in this area to slightly unwind,
effectively raising A6:L5 and with it A6:S6.
This allows the ISR, particularly A6:Y54, to be positioned
low against the N-terminal helix effectively shrinking the cluster
created by A2:L5, -F9, -L33,
-Y54, -V57, and -F59. This prevents
A6:L35 from entering the cluster to the same degree as in
the other proteins (see b). Repositioning of the ISR due to
the shorter N-terminal loop and preventing A6:L35 from
being buried effectively prevent the flip of the
-angle of
A6:L35, and no new hydrogen bonds between
-strands can
be established. These changes keep the beginning part of SW1 in ARF6 as
much as 5 Å away from the positions seen in the other proteins. The
figure was generated with MOLSCRIPT (26).

View larger version (71K):
[in a new window]
Fig. 7.
Structural observations affecting residues
involved in Mg2+ binding. Structurally equivalent
residues in SW1 (A6:E50, A1:E54,
L1:E55, and A2:E54),
2 (A6:S38,
A1:I42, L1:V43, and A2:V42), and
helix
A (A6:Y31, A1:Y35, L1:Y36,
and A2:Y35) of HsARF6 (a), HsARF1
(b), ScARL1 (c), and ScARF2 (d),
respectively, affect the ability of the glutamate in SW1 to interact
with the magnesium ion. The variation in the X1-angle of the indicated
tyrosine in
A in addition to changes in residues at the
start of SW1 (see also Figs. 5 and 6, a-d) allow for the
variation of distance between the tyrosine hydroxyl and the invariant
glutamate in SW1 (yellow line). For HsARF6,
A6:S38 is principally interacting with its
A6:E50 (yellow line). The ability of the
tyrosine to differentially hydrogen bond with the glutamate is
hypothesized to interfere with the binding of the Mg2+
(shown in green when present), which in turn affects
nucleotide affinity and exchange (GDP indicated as
ball-and-stick model). The secondary structures are labeled
and follow the color scheme given in Fig. 1A. The figure was
generated with MOLSCRIPT (26).
-angle, combines with the sequence difference of L1:V43 (A1:I42) to allow
L1:Y36 (A1:Y35) to interact with
L1:E55 (A1:E54). A 90° rotation around X1 of
L1:Y36 in ScARL1 (from
172° in HsARF1 to
79° in
ScARL1) enables the tyrosine hydroxyl to hydrogen bond with
L1:E55 (3.0 Å) (see Fig. 7C), moving
L1:E55 away from its position as an effective
Mg2+ coordinator (10) (see Fig. 7B). The same
rotation of A2:Y35 is observed in ScARF2 (X1 =
82°) as well as the presence of a valine at residue 42, but because
the topology around SW1 is more similar to HsARF1, A2:Y31
cannot approach A2:E54 (5.0 Å) (see Fig. 7D).
This trend is most exaggerated in ARF6. Again the same rotation of
A6:Y31 is observed (X1 =
76°), but because of the
topology divergence in SW1 around this area relative to HsARF1,
A6:Y31 is even further from A6:E50 (8.0 Å)
(Fig. 7A). Instead A6:E50 hydrogen bonds with
A6:S38 (equivalent to residue A1:I42). Thus,
the most dramatic repositioning of the conserved glutamate is found in
HsARF6 (11) followed by ScARL1 and ScARF2, and the nearest approach of
glutamate and magnesium is seen in HsARF1. Although the direct
coordination of magnesium with this conserved glutamate was not seen in
the other HsARF1 structure (24), all of these data are consistent with
this glutamate playing a central role in the binding of magnesium to
members of the ARF family and consequently to the affinity of guanine
nucleotides. This argument was further supported by the recent ARL3-GDP
model in which sequence variations in SW1, similar to those mentioned
above, and the changes of both of the key residues (A1:E54
and A1:Y35) to lysine result in altered binding of
magnesium. In the ARL3-GDP model no Mg2+ is evident but a
SO
![]()
Addendum
subunit of phosphodiesterase (PDE
), was published
during the review of this manuscript (29).
![]()
FOOTNOTES
![]()
ABBREVIATIONS
Nt, N-terminal
-helix;
L-Nt, N-terminal loop.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
1.
Lacal, J. C.,
and McCormick, F.
(1993)
The Ras Superfamily of GTPases
, CRC Press, Boca Raton, FL
2.
Beraud-Dufour, S.,
and Balch, W. E.
(2001)
Methods Enzymol.
329,
245-247[Medline]
[Order article via Infotrieve]
3.
Kahn, R. A.,
Randazzo, P.,
Serafini, T.,
Weiss, O.,
Rulka, C.,
Clark, J.,
Amherdt, M.,
Roller, P.,
Orci, L.,
and Rothman, J. E.
(1992)
J. Biol. Chem.
267,
13039-13046 4.
Zhu, X.,
Boman, A. L.,
Kuai, J.,
Cieplak, W.,
and Kahn, R. A.
(2000)
J. Biol. Chem.
275,
13465-13475 5.
Goldberg, J.
(1998)
Cell
95,
237-248[CrossRef][Medline]
[Order article via Infotrieve]
6.
Goldberg, J.
(1999)
Cell
96,
893-902[CrossRef][Medline]
[Order article via Infotrieve]
7.
Clark, J.,
Moore, L.,
Krasinskas, A.,
Way, J.,
Battey, J.,
Tamkun, J.,
and Kahn, R. A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
8952-8956 8.
Roth, M. G.
(1999)
Trends Cell Biol.
9,
174-179[CrossRef][Medline]
[Order article via Infotrieve]
9.
Tamkun, J. W.,
Kahn, R. A.,
Kissinger, M.,
Brizuela, B. J.,
Rulka, C.,
Scott, M. P.,
and Kennison, J. A.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
3120-3124 10.
Amor, J. C.,
Harrison, D. H.,
Kahn, R. A.,
and Ringe, D.
(1994)
Nature
372,
704-708[CrossRef][Medline]
[Order article via Infotrieve]
11.
Menetrey, J.,
Macia, E.,
Pasqualato, S.,
Franco, M.,
and Cherfils, J.
(2000)
Nat. Struct. Biol.
7,
466-469[CrossRef][Medline]
[Order article via Infotrieve]
12.
Kahn, R. A.
(1991)
Methods Enzymol.
195,
233-242[Medline]
[Order article via Infotrieve]
13.
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
276,
307-326
14.
Navaza, J.
(1994)
Acta Crystallogr. Sect. A
50,
157-163[CrossRef]
15.
Jones, T. A.,
Zou, J. Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr. Sect. A
47,
110-119
16.
Brunger, A. T.,
Adams, P. D.,
Clore, G. M.,
DeLano, W. L.,
Gros, P.,
Grosse-Kunstleve, R. W.,
Jiang, J. S.,
Kuszewski, J.,
Nilges, M.,
Pannu, N. S.,
Read, R. J.,
Rice, L. M.,
Simonson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr. Sect. D Biol. Crystallogr.
54,
905-921[CrossRef][Medline]
[Order article via Infotrieve]
17.
Kahn, R. A.,
Goddard, C.,
and Newkirk, M.
(1988)
J. Biol. Chem.
263,
8282-8287 18.
Hillig, R. C.,
Hanzal-Bayer, M.,
Linari, M.,
Becker, J.,
Wittinghofer, A.,
and Renault, L.
(2000)
Structure
8,
1239-1245[Medline]
[Order article via Infotrieve]
19.
Zhao, L. Y.,
Helms, J. B.,
Brunner, J.,
and Wieland, F. T.
(1999)
J. Biol. Chem.
274,
14198-14203 20.
Inouye, K.,
Mizutani, S.,
Koide, H.,
and Kaziro, Y.
(2000)
J. Biol. Chem.
275,
3737-3740 21.
Zhang, B. L.,
and Zheng, Y.
(1998)
J. Biol. Chem.
273,
25728-25733 22.
Kahn, R. A.,
Terui, T.,
and Randazzo, P. A.
(1996)
J. Lipid Mediat. Cell Signal.
14,
209-214[CrossRef][Medline]
[Order article via Infotrieve]
23.
Kahn, R. A.,
and Gilman, A. G.
(1986)
J. Biol. Chem.
261,
7906-7911 24.
Greasley, S. E.,
Jhoti, H.,
Teahan, C.,
Solari, R.,
Fensome, A.,
Thomas, G. M. H.,
Cockcroft, S.,
and Bax, B.
(1995)
Nat. Struct. Biol.
2,
797-806[CrossRef][Medline]
[Order article via Infotrieve]
25.
Nicholls, A.,
Sharp, K.,
and Honig, B.
(1991)
Proteins Struct. Funct. Genet.
11,
281-296[CrossRef][Medline]
[Order article via Infotrieve]
26.
Esnouf, R. M.
(1999)
Acta Crystallogr. Sect. D Biol. Crystallogr.
55,
938-940[CrossRef][Medline]
[Order article via Infotrieve]
27.
McLachlan, A. D.
(1982)
Acta Crystallogr. Sect. A
38,
871-873[CrossRef]
28.
Martin, A. C. R.
(1998)
Profit, version 1.8
, SciTech Softwarewww.bioinf.org.uk/software
29.
Renault, L.,
Hanzal-Bayer, M.,
and Hillig, R. C.
(2001)
Acta Crystallogr. Sect. D Biol. Crystallogr.
57,
1167-1170[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Splingard, J. Menetrey, M. Perderiset, J. Cicolari, K. Regazzoni, F. Hamoudi, L. Cabanie, A. El Marjou, A. Wells, A. Houdusse, et al. Biochemical and Structural Characterization of the Gem GTPase J. Biol. Chem., January 19, 2007; 282(3): 1905 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Seidel III, J. C. Amor, R. A. Kahn, and J. H. Prestegard Conformational Changes in Human Arf1 on Nucleotide Exchange and Deletion of Membrane-binding Elements J. Biol. Chem., November 12, 2004; 279(46): 48307 - 48318. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hill, Y. Li, M. Bennett, M. McKay, X. Zhu, J. Shern, E. Torre, J. J. Lah, A. I. Levey, and R. A. Kahn Munc18 Interacting Proteins: ADP-RIBOSYLATION FACTOR-DEPENDENT COAT PROTEINS THAT REGULATE THE TRAFFIC OF {beta}-ALZHEIMER'S PRECURSOR PROTEIN J. Biol. Chem., September 19, 2003; 278(38): 36032 - 36040. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grayson, F. Bartolini, J. P. Chapple, K. R. Willison, A. Bhamidipati, S. A. Lewis, P. J. Luthert, A. J. Hardcastle, N. J. Cowan, and M. E. Cheetham Localization in the human retina of the X-linked retinitis pigmentosa protein RP2, its homologue cofactor C and the RP2 interacting protein Arl3 Hum. Mol. Genet., November 15, 2002; 11(24): 3065 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jochum, D. Jackson, H. Schwarz, R. Pipkorn, and B. Singer-Kruger Yeast Ysl2p, Homologous to Sec7 Domain Guanine Nucleotide Exchange Factors, Functions in Endocytosis and Maintenance of Vacuole Integrity and Interacts with the Arf-Like Small GTPase Arl1p Mol. Cell. Biol., July 1, 2002; 22(13): 4914 - 4928. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Click, T. Stearns, and D. Botstein Systematic Structure-Function Analysis of the Small GTPase Arf1 in Yeast Mol. Biol. Cell, May 1, 2002; 13(5): 1652 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bartolini, A. Bhamidipati, S. Thomas, U. Schwahn, S. A. Lewis, and N. J. Cowan Functional Overlap between Retinitis Pigmentosa 2 Protein and the Tubulin-specific Chaperone Cofactor C J. Biol. Chem., April 19, 2002; 277(17): 14629 - 14634. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Sharer, J. F. Sh |